Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon

Joint Commission reverses course, OKs secure clinician texting

The commission's update allows for clinician texting and messaging for “care, treatment, and services…across all accreditation programs.”

States improve quality, reduce costs via reform

States that have implemented health reform options have reduced costs while also maintaining or even improving the quality of care.

NY med schools: clerkships are scarce because of offshore competition

Medical school students in New York are having trouble finding available clinical clerkships because for-profit, offshore medical schools are paying for slots.

Proposed change to Medicare Part B finding little support in Congress

Pilot program would reduce the 6 percent add-on to the average sales price to 2.5 percent plus a flat fee of $16.80 per drug per day

Joint Commission announces new standards on treating eating disorders

Behavioral health care organizations treating eating disorders will be subject to several additional requirements from the Joint Commission.

CMS clarifies Medicaid rules on ex-prisoners in halfway houses

New CMS guidelines for state health officials means 96,000 ex-prisoners currently living in halfway houses can receive Medicaid services.

Senate bill would cap Medicare drug costs at $7,500

Medicare enrollees would have out-of-pocket drug costs capped at $7,500 under a proposed Senate bill that would take effect in 2018.

House proposal would separate CISO, CIO roles within HHS

Change in the CIO-CISO reporting structure was the top recommendation of an August 2015 report by the House Energy and Commerce Committee.

Displaying 2625 - 2632 of 3407

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.